rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Amy L. Ronneberg

Director

Company insider

Files Form 4 as: Director, Actuate Therapeutics; Director, Dianthus Therapeutics; Vice President & Controller, Capella Education Co.

Every Form 4 they filed

In numbers

Trades disclosed
107
Buys
1
Sells
21
Bought
$5,000
Sold
$2.7M
Companies
3
Companies where not an officer
2
First trade
15 Nov 2006
Last trade
21 May 2026
Last filed
22 May 2026

Companies traded

Where they are an officer
Capella Education CoOfficer · last 10 May 20111 buy · 21 sells
Everywhere else they filed: board seats, 10% stakes, other companies
ACTU Actuate TherapeuticsDirector · Biotechnology · last 21 May 20260 buys · 0 sells
DNTH Dianthus TherapeuticsDirector · Biotechnology · last 28 Jun 20220 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
21 May 2026filed 22 May 2026ACTU Actuate Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
21 May 2026filed 22 May 2026ACTU Actuate Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
22 May 2025filed 23 May 2025ACTU Actuate Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
12 Aug 2024filed 14 Aug 2024ACTU Actuate Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
28 Jun 2022filed 30 Jun 2022DNTH Dianthus Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
1 Jun 2021filed 3 Jun 2021DNTH Dianthus Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—18,188 at $0.00filing
5 Jun 2020filed 9 Jun 2020DNTH Dianthus Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—18,188 at $0.00filing
7 Jun 2019filed 11 Jun 2019DNTH Dianthus Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—18,188 at $0.00filing
25 Sep 2018filed 27 Sep 2018DNTH Dianthus Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—52,244 at $0.00filing
25 Jun 2018filed 27 Jun 2018DNTH Dianthus Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code C—1,287,100filing
25 Jun 2018filed 27 Jun 2018DNTH Dianthus Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code C—246,781filing
25 Jun 2018filed 27 Jun 2018DNTH Dianthus TherapeuticsBiotechnologySEC FORM 4 Code C—593,611filing
10 May 2011filed 12 May 2011Capella Education Cooption or derivativeSEC FORM 4 Code A—415 at $0.00filing
10 May 2011filed 12 May 2011Capella Education Cooption or derivativeSEC FORM 4 Code A—305 at $0.00filing
10 May 2011filed 12 May 2011Capella Education Cooption or derivativeSEC FORM 4 Code A—2,130 at $0.00filing
13 Dec 2010filed 14 Dec 2010Capella Education Cooption or derivativeSEC FORM 4 Code M—690 at $0.00filing
13 Dec 2010filed 14 Dec 2010Capella Education CoSEC FORM 4 Code M$29K690 at $42.65filing
13 Dec 2010filed 14 Dec 2010Capella Education CoSEC FORM 4 Sold$42K690 at $61.55filing
8 Dec 2010filed 10 Dec 2010Capella Education Cooption or derivativeSEC FORM 4 Code M—610 at $0.00filing
8 Dec 2010filed 10 Dec 2010Capella Education CoSEC FORM 4 Code M$12K610 at $20.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed22

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.